Evaluating post-surgery radiation treatment for Dupuytren's disease
Official title: Efficacy of Post-contracture Release Radiation for the Treatment of Dupuytren's Disease
Run by University of Minnesota · NCT04122313 · Data updated 2026-11-12
This study is testing whether adding radiation treatment after surgery for Dupuytren's disease can help improve hand function and reduce symptoms for patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University of Minnesota Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Minneapolis, Minnesota) |
| Status | Recruiting |
| Started | May 31, 2019 |
| Main results expected | March 1, 2029 |
| Study ends | March 1, 2029 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT04122313 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are English-speaking individuals diagnosed with Dupuytren's disease who are actively seeking treatment.
✕Probably not a fit
Patients with Dupuytren's disease who are not currently seeking treatment will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational pilot study aims to assess the effectiveness of a treatment pathway for Dupuytren's disease, which includes surgical contracture release followed by radiation therapy. Participants will receive a standard treatment involving limited fasciectomy, PNA, or CCH injection, followed by a series of radiation treatments. Data will be collected on participants' symptoms and hand function at various intervals to evaluate the clinical outcomes of the treatment. The study seeks to substantiate clinicians' impressions of patient improvement with scientific evidence.
Why it matters
Potential benefit: If successful, this study could provide evidence-based support for a treatment approach that may improve outcomes for patients with Dupuytren's disease.
How similar studies have gone: While this approach is based on established treatment protocols, the specific observational nature of this study may provide new insights into its effectiveness.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnoses of Dupuytren's disease * English-speaking Exclusion Criteria: \- Patients with Dupuytren's disease who are not currently seeking treatment
Where it's running
-
University of Minnesota
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Leslie Chang — University of Minnesota
- Study coordinator: Leslie Chang
- Email: dupuytrensumn@umn.edu
- Phone: 612-273-6014
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CNT201 collagenase injection for Dupuytren’s: safety and signals of efficacy in adults
A randomized, placebo-controlled study will test CNT201 injections to see if they are safe and help improve finger contractures in adults with Dupuytren’s disease.
-
Treatment options for Dupuytren's contracture
This study is testing whether adding a corticosteroid injection to a needle treatment helps people with Dupuytren's contracture move their fingers better.
-
Evaluating night splinting after needle fasciotomy for Dupuytren's contracture
This study is testing if wearing a night splint after a needle procedure for Dupuytren's contracture can help prevent the condition from coming back compared to just physical therapy alone.
-
Evaluating a new ultrasound-guided technique for Dupuytren's contracture
This study is testing a new ultrasound-guided procedure to see if it can safely improve hand function for people with Dupuytren's contracture while causing fewer problems than traditional surgery.
-
Using radiation therapy to prevent Dupuytren's contracture recurrence after treatment
This study is testing if targeted radiation therapy can help prevent Dupuytren's contracture from coming back after treatment in people aged 45 and older.
-
Treatment for early Dupuytren's disease using vitamin E cream
This study is testing if using vitamin E cream can help people with early Dupuytren's disease stop their fingers from getting worse.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.